Dice CEO: Energy, T...
Health Care: Drugs
EpiCept Corporation (EPCT: OTC)
$0.17 -0.01 | -5.00%
06/01/12 - 02:25 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| EPCT | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -32.00 | -39.29 | 0.00 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 140.10 | 2.04 | 0.44 |
| Net Income | -0.46 | 0.00 | |
| EPS | -0.86 | 0.00 |
Earnings for EPCT:
| EBITDA | -15.00 |
| REVENUE | 994.00K |
Average Earnings Estimates
| Qtr (06/12) | Qtr (09/12) | FY (12/12) | FY (12/13) | |
|---|---|---|---|---|
| Average Estimate | $-0.04 | $-0.04 | $-0.16 | $-0.22 |
| Number of Analysts | 1 | 1 | 1 | 1 |
| High Estimate | $-0.04 | $-0.04 | $-0.16 | $-0.22 |
| Low Estimate | $-0.04 | $-0.04 | $-0.16 | $-0.22 |
| Prior Year | $-0.06 | $-0.08 | $-0.23 | $-0.16 |
| Growth Rate (Year over Year) | 33.33% | 50.00% | 30.43% | -37.50% |
Portfolios with EPCT
- Portfolio NameUser Type
- Usergdean1
- Usernoneya Portfolio 1
- UserBAMAITAL
- UserPANTERA GROUP 146
- Userunlikely
- Useryinghcho Portfolio 1
- Usersmall caps with good futures
- UserBENITRANS DH
- Userindo
- UserEmerging Cancer
Latest EPCT Headlines from TheStreet
- Biotech Sector Weekly Rewind 12.11.10 | 08:12 am
- Bankruptcy Watch: Stocks Under $5 09.16.10 | 06:09 am
- Stock Offerings: EpiCept 06.28.10 | 09:06 am
- EpiCept 3Q Loss Narrows On Lower Costs 11.10.09 | 03:11 pm
- Biotech Stock Mailbag: Cyclacel Pharma 09.18.09 | 07:09 am
- Biotech Mailbag: Study Boosts ImmunoGen 10.17.08 | 11:10 am
- Thursday's Health Winners & Losers 08.06.07 | 09:08 pm
- Friday's Small-Cap Winners & Losers 06.29.07 | 02:06 pm
- Friday's Health Winners & Losers 06.15.07 | 04:06 pm
- Studies Pep Up EpiCept 05.02.07 | 09:05 pm
Press Releases for EPCT
- EpiCept Corporation Receives Scientific Advice From European Medicines Agency For AmiKet™ CIPN Program - Business Wire 06.04.12 | 12:06 am
- EpiCept’s AmiKet™ Receives Fast Track Designation From FDA - Business Wire 04.10.12 | 12:04 am
- EpiCept’s Licensed Compound EP1013 Identified As A New Drug Candidate For Treatment Of Late-Stage Viral Hepatitis - Business Wire 04.04.12 | 12:04 am
- EpiCept To Raise $1.1 Million In Registered Direct Offering - Business Wire 03.29.12 | 12:03 am
- EpiCept Corporation To Present At The BIO-Europe Spring 2012 Event - Business Wire 03.14.12 | 05:03 pm
- EpiCept Reports Fourth Quarter And Full Year 2011 Operating And Financial Results - Business Wire 02.29.12 | 12:02 am
- EpiCept Corporation To Report Fourth Quarter And Full Year 2011 Operating And Financial Results On February 29, 2012 - Business Wire 02.23.12 | 05:02 pm
- EpiCept To Raise $2 Million In Registered Direct Offering - Business Wire 02.08.12 | 11:02 pm
- EpiCept To Present At The 14th Annual BIO CEO & Investor Conference - Business Wire 02.08.12 | 05:02 pm
- EpiCept Files For AmiKet™ Fast Track Designation - Business Wire 02.07.12 | 12:02 am
Partner Headlines for EPCT
- Biotechs to Watch at the 2012 San Francisco Healthcare Confrences - Analyst Blog - Zacks 01.09.12 | 07:01 am
- Zacks Maintains Outperform on EpiCept - Benzinga 08.16.11 | 09:08 am
- EpiCept's Promising Leukemia Drug: A Buying Opportunity? - Seeking Alpha 10.15.10 | 02:10 pm
- China Analyst: 10 Pharma Stocks With Highest Growth Potential - Seeking Alpha 10.08.10 | 06:10 am
- FDA Committee Rejects Expanded Use of Jazz Drug on Abuse Concerns: Biotech's Latest Failures - Seeking Alpha 08.30.10 | 08:08 am
- Tech Stocks Fly, Pharma Stocks Cry! (DELL, HPQ, PAR, CML, CVLT, ISLN, TPL, JAZZ, EPCT, CPIX) - Benzinga 08.23.10 | 01:08 pm
- Epicept: Good Play in Light of Recent Developments - Seeking Alpha 06.02.10 | 03:06 am
- Three Promising Small-Cap Cancer Plays - Seeking Alpha 05.17.10 | 08:05 am
